Doudna-Charpentier team awarded U.S. patent for CRISPR-Cas9

The University of California announced today that the United States Patent and Trademark Office has granted patent number 10,000,772 covering the use of CRISPR-Cas9 gene editing with formats that will be particularly useful in developing human therapeutics and improvements in food security.